Milgamma (Benfotiamine, Pyridoxine Hydrochloride)

Benfotiamine, the active ingredient in Milgamma, is a vitamin supplement presented as an oral dosage form for oral use. It, together with pyridoxine hydrochloride, is used to support carbohydrate metabolism and nerve function in individuals with vitamin B1 and B6 deficiencies or diabetic peripheral neuropathy.

GNH USA supplies Milgamma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑controlled batches for global distribution and compliance with EU standards.

Milgamma, containing benfotiamine and pyridoxine, is used to address disorders related to vitamin B1 and B6 deficiency and peripheral nerve dysfunction. - Diabetic peripheral neuropathy: helps alleviate nerve pain and sensory deficits associated with long‑term diabetes. - Peripheral nerve disorders: supports nerve health and may improve symptoms in various neuropathic conditions. - Vitamin B1 deficiency: restores thiamine levels, aiding carbohydrate metabolism. - Vitamin B6 deficiency: replenishes pyridoxine, facilitating amino‑acid metabolism and neurotransmitter synthesis.

Milgamma may be associated with several adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild stomach upset reported by some users. - Headache: transient headache episodes. - Gastrointestinal discomfort: occasional abdominal pain or dyspepsia. - Skin rash: mild erythema or itching.

Serious or Rare Side Effects: - Hypersensitivity reaction: signs of anaphylaxis such as swelling, difficulty breathing. - Severe skin eruption: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hematologic changes: rare cases of leukopenia or thrombocytopenia. - Liver enzyme elevation: uncommon increase in hepatic transaminases.

When considering Milgamma, several precautions should be observed to ensure safe use. - Pregnancy: safety has not been established; use only if potential benefit justifies risk. - Breastfeeding: caution advised as excretion in milk is unknown. - Renal impairment: monitor renal function, dose may need adjustment. - Drug hypersensitivity: avoid if known allergy to benfotiamine or pyridoxine. - Concomitant medications: review for potential interactions with anticoagulants or antiepileptics. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original container.

Milgamma can interact with certain medicines, affecting either its efficacy or the co‑administered drug.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): high doses of vitamin B6 may potentiate anticoagulant effect. - Antiepileptic drugs (e.g., phenytoin): pyridoxine may reduce seizure control.

Moderate Interactions (Monitor Closely): - Diuretics: may increase urinary loss of B vitamins. - Metformin: potential additive effect on glucose metabolism. - Chemotherapeutic agents: high‑dose B vitamins could interfere with certain cytotoxic mechanisms.